Feline Atopic Dermatitis Drug Market Report 2024 (Global Edition)

Global Feline Atopic Dermatitis Drug Market Report 2024 Market Size Split by Drug Class (Corticosteroids, Antihistamines, Antibiotics), by Route of Administration (Oral, Topical, Injectable), by Distr...

Feline Atopic Dermatitis Drug Market Report Description

We have various report editions of Feline Atopic Dermatitis Drug Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Feline Atopic Dermatitis Drug Market Insights Video

Competitive Landscape of the Feline Atopic Dermatitis Drug Market

The competitive landscape of the feline atopic dermatitis drug market is characterized by a range of players competing to gain market share through product innovation, strategic partnerships, and aggressive marketing efforts. Key players in the market include established corticosteroid drug manufacturers, specialized feline atopic dermatitis drug companies, and emerging start-ups aiming to disrupt the market with innovative solutions.

January 2022: According to a Zoetis announcement, the European Commission (EC) has authorized the commercialization of Apoquel chewable tablets (oclacitinib) for the treatment of clinical symptoms of atopic dermatitis in dogs that are at least 12 months old. (Source: https://news.zoetis.com/press-releases/press-release-details/2022/Zoetis-Receives-European-Commission-Marketing-Authorization-for-APOQUEL-chewable-tablets-oclacitinib-for-the-treatment-of-itch-and-inflammation-in-allergic-dogs/#:~:text=ZAVENTEM%2C%20BELGIUM%2C%20January%2010%2C,and%20the%20treatment%20of%20clinical) October 2021: GSK's cephalosporin antibiotics business was acquired by Sandoz, a Novartis company. Sandoz's status as the world's top antibiotics company was reinforced by gaining rights to three well-known brands (Zinnat, Zinacef, and Fortum) in more than 100 markets. (Source: https://www.novartis.com/news/media-releases/sandoz-completes-acquisition-gsks-cephalosporin-business-reinforcing-leading-global-position-antibiotics) April 2021: AbbVie filed a supplementary new drug application (sNDA) to extend the evaluation period for RINVOQ in adults and adolescents with atopic dermatitis. The PDUFA timeline was extended through the third quarter of 2021. (Source: https://news.abbvie.com/2021-04-02-AbbVie-Announces-Extension-of-Review-for-Supplemental-New-Drug-Application-of-Upadacitinib-for-the-Treatment-of-Moderate-to-Severe-Atopic-Dermatitis)

Top Companies Market Share in Feline Atopic Dermatitis Drug Industry: (In no particular order of Rank)

• Bausch Health Companies
• Bayer
• Pfizer
• Novartis
• Sanofi
• Eli Lily
• Bristol-Myers Squibb
• C. H. Boehringer Sohn
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Feline Atopic Dermatitis Drug Market

Which Region Dominates the Feline Atopic Dermatitis Drug Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue. Innovative drug research, a growing tendency toward customized therapy, and a greater emphasis on preventative healthcare for cats are the key factors that define the North American Feline Atopic Dermatitis Drug Market. Because so many people in North America own pets, there is a big market for pharmaceutical companies to enter by offering cutting-edge feline atopic dermatitis treatment alternatives. Strong healthcare spending and the region's well-developed healthcare infrastructure both contribute to market expansion. Furthermore, the focus on strategic alliances, education programs, and research collaborations offers profitable prospects for market expansion in North America. It advances the diagnosis and treatment of atopic dermatitis in cats.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the Feline Atopic Dermatitis Drug market. Feline Atopic Dermatitis Drugs are becoming more and more popular in the Asia Pacific region as a means of treating itching. Growing passion for animals, increasing financial resources, and an increased emphasis on the health and well-being of pets are some of the causes driving this demand. Due to the region's high domestic cat ownership rate and rising knowledge of feline atopic dermatitis, pharmaceutical businesses now have a chance to enter the market with high-quality itching alleviation products. In addition, the Asia Pacific region's increased availability and accessibility of feline atopic dermatitis medications can be attributed to developments in animal health care, growing distribution networks, and an increasing number of significant market participants.

The current report Scope analyzes Feline Atopic Dermatitis Drug Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Feline Atopic Dermatitis Drug Market

According to Cognitive Market Research, the global Feline Atopic Dermatitis Drug market size was estimated at USD 2864.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 1145.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.2% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Feline Atopic Dermatitis Drug market with a market size of USD 904.04 million in 2024 and is projected to grow at a CAGR of 14.0% during the forecast period. The United States has a high pet ownership rate, with many households viewing their pets as part of the family. Significant money is spent on veterinary care, including atopic dermatitis treatments, because of this emotional attachment.
• The Canada Feline Atopic Dermatitis Drug market had a market share of USD 137.50 million in 2024 and is projected to grow at a CAGR of 15.0% during the forecast period. The demand for feminine atopic dermatitis medication is being driven by Canada's growing pet population and increased rates of pet ownership.
• The Mexico Feline Atopic Dermatitis Drug market is projected to witness growth at a CAGR of 14.7% during the forecast period, with a market size of USD 104.27 million in 2024.

Europe Feline Atopic Dermatitis Drug Market

According to Cognitive Market Research, the global Feline Atopic Dermatitis Drug market size was estimated at USD 2864.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 859.35 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.5% from 2024 to 2031.

• The United Kingdom Feline Atopic Dermatitis Drug market had a market share of USD 144.37 million in 2024 and is projected to grow at a CAGR of 15.3% during the forecast period. Due to the large percentage of pet ownership in the UK, there is a steady need for products related to feline healthcare, such as treatments for atopic dermatitis.
• The France Feline Atopic Dermatitis Drug market is projected to witness growth at a CAGR of 13.7% during the forecast period, with a market size of USD 79.06 million in 2024.
• According to Cognitive Market Research, the German Feline Atopic Dermatitis Drug market size was valued at USD 170.15 million in 2024 and is projected to grow at a CAGR of 14.7% during the forecast period. The strong pharmaceutical sector in Germany facilitates the creation and accessibility of novel treatments for atopic dermatitis.
• The Italy Feline Atopic Dermatitis Drug market is projected to witness growth at a CAGR of 13.9% during the forecast period, with a market size of USD 73.90 million in 2024.
• The Russia Feline Atopic Dermatitis Drug market is projected to witness growth at a CAGR of 13.5% during the forecast period, with a market size of USD 133.20 million in 2024.
• The Spain Feline Atopic Dermatitis Drug market is projected to witness growth at a CAGR of 13.6% during the forecast period with a market size of USD 70.47 million in 2024
• The Luxembourg Feline Atopic Dermatitis Drug market is projected to witness growth at a CAGR of 14.6% during the forecast period, with a market size of USD 26.64 million in 2024.
• The Portugal Feline Atopic Dermatitis Drug market is projected to witness growth at a CAGR of 14.3% during the forecast period, with a market size of USD 18.05 million in 2024.
• The Greece Feline Atopic Dermatitis Drug market is projected to witness growth at a CAGR of 14.8% during the forecast period, with a market size of USD 10.31 million in 2024.
• Rest of Europe's Feline Atopic Dermatitis Drug market is projected to witness growth at a CAGR of 13.2% during the forecast period, with a market size of USD 133.20 million in 2024.

Asia Pacific Feline Atopic Dermatitis Drug Market

According to Cognitive Market Research, the global Feline Atopic Dermatitis Drug market size was estimated at USD 2864.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 658.84 million in 2024 and will grow at a compound annual growth rate (CAGR) of 18.0% from 2024 to 2031.

• According to Cognitive Market Research, the China Feline Atopic Dermatitis Drug market size was valued at USD 296.48 million in 2024 and is projected to grow at a CAGR of 17.5% during the forecast period. Growing expenditure on pet wellness and healthcare due to China's growing middle class has contributed to the market's expansion.
• The Japan Feline Atopic Dermatitis Drug market is projected to witness growth at a CAGR of 16.5% during the forecast period, with a market size of USD 90.92 million in 2024.
• The India Feline Atopic Dermatitis Drug market had a market share of USD 79.06 million in 2024 and is projected to grow at a CAGR of 19.8% during the forecast period. Atopic dermatitis treatments and veterinary care are in great demand due to India's increasing rate of pet adoption in metropolitan regions.
• The South Korean Feline Atopic Dermatitis Drug market is projected to witness growth at a CAGR of 17.1% during the forecast period, with a market size of USD 65.88 million in 2024.
• The Australian Feline Atopic Dermatitis Drug market is projected to witness growth at a CAGR of 17.7% during the forecast period, with a market size of USD 34.26 million in 2024.
• The South East Asia Feline Atopic Dermatitis Drug market is projected to witness growth at a CAGR of 19.0% during the forecast period, with a market size of USD 45.46 million in 2024.
• The Rest of Asia Pacific Feline Atopic Dermatitis Drug market is projected to witness growth at a CAGR of 17.8% during the forecast period, with a market size of USD 46.78 million in 2024.

South America Feline Atopic Dermatitis Drug Market

According to Cognitive Market Research, the global Feline Atopic Dermatitis Drug market size was estimated at USD 2864.5 Million, out of which the Latin America market has more than 5% share of the global revenue with a market size of USD 143.23 million in 2024 and will grow at a compound annual growth rate (CAGR) of 15.4% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Feline Atopic Dermatitis Drug market size was valued at USD 61.30 million in 2024 and is projected to grow at a CAGR of 16.0% during the forecast period. Atopic dermatitis medications and other cat healthcare products are in constant demand in Brazil due to the country's high pet population.
• Argentina's Feline Atopic Dermatitis Drug market had a market share of USD 24.06 million in 2024 and is projected to grow at a CAGR of 16.3% during the forecast period. The need for dermatological treatments is growing in Argentina as a result of cultural beliefs that place a high value on the health and welfare of pets.
• Colombia Feline Atopic Dermatitis Drug market is projected to witness growth at a CAGR of 15.2% during the forecast period, with a market size of USD 12.75 million in 2024.
• Peru Feline Atopic Dermatitis Drug market is projected to witness growth at a CAGR of 15.6% during the forecast period, with a market size of USD 11.74 million in 2024.
• Chile's Feline Atopic Dermatitis Drug market is projected to witness growth at a CAGR of 15.7% during the forecast period, with a market size of USD 10.31 million in 2024.
• The Rest of Latin America's Feline Atopic Dermatitis Drug market is projected to witness growth at a CAGR of 14.5% during the forecast period, with a market size of USD 23.06 million in 2024.

Middle East and Africa Feline Atopic Dermatitis Drug Market

According to Cognitive Market Research, the global Feline Atopic Dermatitis Drug market size was estimated at USD 2864.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 57.29 million in 2024 and will grow at a compound annual growth rate (CAGR) of 15.7% from 2024 to 2031..

• The GCC Countries Feline Atopic Dermatitis Drug market is projected to witness growth at a CAGR of 16.5% during the forecast period, with a market size of USD 24.52 million in 2024. The requirement for complete pet healthcare services, including dermatitis treatments, is being driven by a rise in pet ownership in the GCC countries.
• The Egypt Feline Atopic Dermatitis Drug market is projected to witness growth at a CAGR of 16.0% during the forecast period, with a market size of USD 6.02 million in 2024.
• The South Africa Feline Atopic Dermatitis Drug market is projected to witness growth at a CAGR of 16.7% during the forecast period, with a market size of USD 9.05 million in 2024. The demand for feline healthcare goods, such as atopic dermatitis treatments, is being driven by South Africa's expanding pet population.
• The Turkey Feline Atopic Dermatitis Drug market is projected to witness growth at a CAGR of 15.2% during the forecast period, with a market size of USD 4.93 million in 2024.
• The Nigeria Feline Atopic Dermatitis Drug market is projected to witness growth at a CAGR of 14.8% during the forecast period, with a market size of USD 6.02 million in 2024.
• The Rest of the MEA Feline Atopic Dermatitis Drug market is projected to witness growth at a CAGR of 14.7% during the forecast period, with a market size of USD 6.76 million in 2024.

Feline Atopic Dermatitis Drug Market Analysis

Feline Atopic Dermatitis Drug Market Drug Class Segment Analysis

According to Cognitive Market Research, Corticosteroids stand out as the dominant category over the projected period. As corticosteroids work quickly to reduce inflammation and relieve itching, they are highly sought after in the market for drugs for feline atopic dermatitis. They provide cats with instant relief from allergic skin issues and are a commonly suggested therapy choice. Veterinarians and pet owners alike favor them because of their low cost and rapid results. However, long-term corticosteroid use may be restricted due to possible side effects such as immunological suppression and metabolic problems. Notwithstanding these reservations, corticosteroids continue to be a mainstay in the treatment of feline atopic dermatitis due to their function in acute flare-ups and cost-effectiveness.

Antihistamines emerge as the fastest-growing category in the Feline Atopic Dermatitis Drug market. Due to their capacity to control allergic symptoms like itching and inflammation, antihistamines are becoming more and more in demand in the market for drugs for feline atopic dermatitis. These drugs cure the symptoms of atopic dermatitis in cats by inhibiting histamines, which are substances implicated in allergic reactions. Antihistamines are a common option for the acute and long-term treatment of allergic reactions since they are less expensive and have fewer adverse effects than corticosteroids. Their constant popularity in the market is a result of their frequent recommendations for use as an adjuvant to other therapies or as initial therapy.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Feline Atopic Dermatitis Drug Industry. Request a Free Sample PDF!

Feline Atopic Dermatitis Drug Market Route of Administration Segment Analysis

According to Cognitive Market Research, the dominant category is Oral. Because it's so convenient and simple to administer, the oral mode of administration for feline atopic dermatitis medications is in high demand. Oral drugs, such as corticosteroids, antihistamines, and more recent targeted medicines, provide a simple means of administering treatment at regular intervals. Veterinarians and pet owners favor oral medications because they are simpler to administer than topical therapies, which can be difficult to apply correctly and may need to be used more frequently. Additionally, systemic therapy of atopic dermatitis disease is possible via the oral route, which can be very helpful in managing severe or extensive cases of the condition.

The fastest-growing category in the Feline Atopic Dermatitis Drug market is Topical. Because topical medication takes a focused approach to treating localized skin concerns, it is becoming more and more popular in the market for feline atopic dermatitis drugs. Pharmaceutical shampoos, lotions, and dressings are examples of topical treatments that target the problem areas directly and reduce inflammation and itching while having very little impact on the rest of the body. In order to boost overall condition management, they are frequently used in conjunction with oral medicines. Because topical therapies can handle mild to severe cases of atopic dermatitis and provide localized therapy, they are valued as a comprehensive care choice by both veterinarians and pet owners.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Feline Atopic Dermatitis Drug Distribution Channel Segment Analysis

Feline Atopic Dermatitis Drug Market Distribution Channel Segment Analysis

According to Cognitive Market Research, Veterinary Pharmacies stand out as the dominant category over the projected period. As cat allergic reactions to the skin become more common and pet owners become more knowledgeable about treating these disorders, there is a growing need for feline atopic dermatitis medications from veterinary pharmacies. A vast array of drugs, such as corticosteroids, antihistamines, and topical therapies specifically designed for feline use, are available from these pharmacies, which act as vital distribution hubs. They serve veterinarians and animal owners looking for atopic dermatitis treatments that work well and are approved by veterinarians. Demand is also stimulated by the ease with which veterinary pharmacies can provide prescription and over-the-counter medications, improving accessibility. To further aid in the better management of feline skin disorders, veterinarian pharmacies frequently provide advice on how to utilize medications.

Retail Pharmacies emerge as the fastest-growing category in the Feline Atopic Dermatitis Drug market. With more people owning pets and being more conscious of pet health, retail pharmacies are noticing a growth in demand for feline atopic dermatitis medications. These pharmacies offer easily accessible solutions for pet owners looking for over-the-counter medications to address their cats' skin-related allergies. For those seeking instant symptom alleviation, products, including antihistamines, moisturizing lotions, and specialty shampoos, are well-liked options. Pet owners can conveniently obtain necessary remedies without requiring a veterinary visit, thanks to the availability of retail pharmacies, which are frequently found in urban and suburban regions. Retail pharmacies are important for satisfying the increasing need for pet care as they continue to be incorporated into everyday retail experiences.

• Veterinary Pharmacies
• Retail Pharmacies
• Online Pharmacies

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion